Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Lantheus Holdings Is Dropping Today

TheMotleyFool

0 0

Why Lantheus Holdings Is Dropping TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Shares of Lantheus Holdings (NASDAQ: LNTH), a company focused on diagnostic medical imaging equipment and supplies, dropped 21% as of 10:35 a.m. EDT on Wednesday after the company announced that it is acquiring Progenics Pharmaceuticals (NASDAQ: PGNX), a commercial-stage biotechnology company focused on cancer.

Here are the key terms of the deal:

Traders don't appear to share management's enthusiasm for the deal and are responding accordingly.

Source Fool.com

Like: 0

PGNX

Teilen